Drugs Made In America Acquisition Corp. (DMAA)
NASDAQ: DMAA · Real-Time Price · USD
Drugs Made In America Acquisition currently trades with the ticker symbol DMAAU
9.97
0.00 (0.00%)
Feb 27, 2025, 4:00 PM EST - Market open
Company Description
Drugs Made In America Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses in the pharmaceutical industry.
The company was incorporated in 2024 and is based in Fort Lauderdale, Florida.
Drugs Made In America Acquisition Corp.
| Country | United States |
| Founded | 2024 |
| IPO Date | Jan 28, 2025 |
| Industry | Shell Companies |
| Sector | Financials |
| CEO | Lynn Stockwell |
Contact Details
Address: 1 East Broward Boulevard, Suite 700 Fort Lauderdale, Florida 33301 United States | |
| Phone | (954) 870-3099 |
| Website | dmaacorp.com |
Stock Details
| Ticker Symbol | DMAA |
| Exchange | NASDAQ |
| Reporting Currency | USD |
| IPO Price | $10.00 |
| CIK Code | 0002028614 |
| SIC Code | 6770 |
Key Executives
| Name | Position |
|---|---|
| Lee Seng Chi | Chief Executive Officer, Director, and Chairman of the Board of Directors |
| See Sian Seong | Chief Financial Officer |
| Thien Chiet Chai | Non-executive Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Feb 25, 2025 | 8-K | Current Report |
| Feb 24, 2025 | 8-K | Current Report |
| Feb 4, 2025 | 8-K | Current Report |
| Jan 30, 2025 | 8-K | Current Report |
| Jan 29, 2025 | 424B4 | Prospectus |
| Jan 27, 2025 | EFFECT | Notice of Effectiveness |
| Jan 22, 2025 | POS AM | Post-Effective amendments for registration statement |
| Jan 14, 2025 | POS AM | Post-Effective amendments for registration statement |
| Jan 8, 2025 | CERT | Certification by an exchange approving securities for listing |
| Jan 7, 2025 | EFFECT | Notice of Effectiveness |